摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Hydroxy-3-methyl-butansaeureamid | 88512-09-8

中文名称
——
中文别名
——
英文名称
3-Hydroxy-3-methyl-butansaeureamid
英文别名
3-Hydroxy-3-methyl-buttersaeureamid;3-Hydroxy-isovaleriansaeureamid;β-hydroxy-isovaleric acid amide;3-Hydroxy-3-methyl-butyramid;β-Hydroxy-isovaleriansaeure-amid;3-hydroxyisovaleramide;3-Hydroxy-3-methylbutanamide
3-Hydroxy-3-methyl-butansaeureamid化学式
CAS
88512-09-8
化学式
C5H11NO2
mdl
MFCD19203969
分子量
117.148
InChiKey
QHNHAWNULKRVMJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1
  • 重原子数:
    8
  • 可旋转键数:
    2
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    63.3
  • 氢给体数:
    2
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    3-Hydroxy-3-methyl-butansaeureamid 、 在 (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 1.0h, 以50%的产率得到N-[[4-(4-fluorophenyl)sulfonyl-7-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2,3-dihydro-1,4-benzothiazin-2-yl]methyl]-3-hydroxy-3-methylbutanamide
    参考文献:
    名称:
    Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
    摘要:
    We disclose the optimization of a high throughput screening hit to yield benzothiazine and tetrahydroquinoline sulfonamides as potent ROR gamma t inverse agonists. However, a majority of these compounds showed potent activity against pregnane X receptor (PXR) and modest activity against liver X receptor alpha (LXR alpha). Structure-based drug design (SBDD) led to the identification of benzothiazine and tetrahydro-quinoline sulfonamide analogs which completely dialed out LXR alpha activity and were less potent at PXR. Pharmacodynamic (PD) data for compound 35 in an IL-23 induced IL-17 mouse model is discussed along with the implications of a high Y-max in the PXR assay for long term preclinical pharmacokinetic (PK) studies. (C) 2017 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2017.12.006
  • 作为产物:
    参考文献:
    名称:
    β-Propiolactone. XIV.1 β-Isovalerolactone
    摘要:
    DOI:
    10.1021/ja01631a045
点击查看最新优质反应信息

文献信息

  • Graf,R., Justus Liebigs Annalen der Chemie, 1963, vol. 661, p. 111 - 157
    作者:Graf,R.
    DOI:——
    日期:——
  • β-Propiolactone. XIV.<sup>1</sup> β-Isovalerolactone
    作者:T. L. Gresham、J. E. Jansen、F. W. Shaver、W. L. Beears
    DOI:10.1021/ja01631a045
    日期:1954.1
  • Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity
    作者:Hua Gong、David S. Weinstein、Zhonghui Lu、James J.-W. Duan、Sylwia Stachura、Lauren Haque、Ananta Karmakar、Hemalatha Hemagiri、Dhanya Kumar Raut、Arun Kumar Gupta、Javed Khan、Dan Camac、John S. Sack、Andrew Pudzianowski、Dauh-Rurng Wu、Melissa Yarde、Ding-Ren Shen、Virna Borowski、Jenny H. Xie、Huadong Sun、Celia D'Arienzo、Marta Dabros、Michael A. Galella、Faye Wang、Carolyn A. Weigelt、Qihong Zhao、William Foster、John E. Somerville、Luisa M. Salter-Cid、Joel C. Barrish、Percy H. Carter、T.G. Murali Dhar
    DOI:10.1016/j.bmcl.2017.12.006
    日期:2018.1
    We disclose the optimization of a high throughput screening hit to yield benzothiazine and tetrahydroquinoline sulfonamides as potent ROR gamma t inverse agonists. However, a majority of these compounds showed potent activity against pregnane X receptor (PXR) and modest activity against liver X receptor alpha (LXR alpha). Structure-based drug design (SBDD) led to the identification of benzothiazine and tetrahydro-quinoline sulfonamide analogs which completely dialed out LXR alpha activity and were less potent at PXR. Pharmacodynamic (PD) data for compound 35 in an IL-23 induced IL-17 mouse model is discussed along with the implications of a high Y-max in the PXR assay for long term preclinical pharmacokinetic (PK) studies. (C) 2017 Elsevier Ltd. All rights reserved.
查看更多